Amazec Photonics, a pioneering Dutch startup in the field of photonics, has recently closed a significant €1.5 million Seed Round to propel the development of their groundbreaking minimally invasive medical diagnosis devices. Spearheaded by PhotonDelta, a prominent cross-border growth accelerator and an ecosystem of photonic chip technology organizations, this funding round also saw enthusiastic participation from various private investors.
The primary focus of this investment is to drive the advancement of medical devices tailored for clinical trials. With cardiovascular diseases standing as the world’s leading cause of mortality, claiming a staggering 19 million lives annually, the importance of early and accurate diagnoses cannot be overstated. The existing challenge lies in the delay in treatment due to the complexities in diagnosis.
At the forefront of this battle against cardiovascular diseases, Amazec Photonics introduces a cutting-edge solution set to revolutionize diagnostic practices. Their state-of-the-art technology offers a cost-effective and minimally intrusive approach, enabling significantly earlier and more precise diagnoses.
Unparalleled Precision: By leveraging photonics-based technologies, Amazec's devices can detect temperature changes with an astonishing accuracy of 0.0001˚C, a significant leap from the current industry standard of 0.01˚C.
Non-invasive Monitoring: Unlike conventional methods that often require invasive procedures, Amazec's monitoring tools are designed to be external, eliminating the need for catheter insertions.
Real-Time Measurements: Offering a substantial improvement in reliability, Amazec's devices facilitate multiple real-time measurements, diverging from the limited single measurements typical of existing methodologies.
With their innovative approach and commitment to transforming cardiovascular monitoring, Amazec Photonics is poised to make a lasting impact in the realm of medical diagnosis, paving the way for more effective and timely interventions.
English
USD $
